Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Trial of Losartan/HCTZ vs Losartan/Amlodipine in Uncontrolled Hypertension
NCT00492128Phase 4Completed
- Sponsor
- Yokohama City University Medical Center
- Start
- Sep 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of losartan + hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Yokohama City University Medical Center. Primary endpoint: The change of systolic blood pressure at 3 months. Started Sep 2007; status: completed.
02
Drugs
losartan + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00492128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492128.